Skip to main content

Table 2 Subscales of the Reflux Disease Questionnaire and GERD Score at Visit 1 and 2 and results of tests for significance, significant differences between visits are written in bold, mean ± 95% CI.

From: Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy

RDQ

Score

 

Visit 1

Visit 2

p-value

Regurgitation Subscale

2.8 ± 0.3

1.7 ± 0.3

< 0.0001

Heartburn Subscale

3.4 ± 0.1

2.0 ± 0.4

< 0.0001

Dyspepsia Subscale

2.3 ± 0.3

1.5 ± 0.3

< 0.0001

GERD Score

6.2 ± 0.4

3.7 ± 0.7

< 0.0001

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us